FACED-UP: Fast Analysis of CErvical Dystonia * Unobtrusive and Precise

FACED-UP: Fast Analysis of CErvical Dystonia * Unobtrusive and Precise - FACED-UP

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

NL-OMON

Registry ID

NL-OMON42860

Enrollment

Registered

2016-08-08

Start date

2016-09-26

Completion date

Unknown

Last updated

2024-04-23

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cervical Dystonia (Torticollis)

Interventions

None listed

Eligibility

Age

18 Years to 99 Years

Inclusion criteria

Inclusion criteria: All participants: 18 years or older, male/female, have command of the Dutch language Additional for Cervical Dystonia (CD): Diagnosed with CD, registered at the LUMC Additional for Essential Tremor (ET): Diagnosed with ET, registered at the LUMC

Exclusion criteria

Exclusion criteria: * lesions or diseases of the central nervous system * additional neurological and/or orthopedic problems interfering function of the neck, arm or back *

Design outcomes

Primary

Measure	Time frame
Parameters related to postures and movements of the head (e.g., resting posture, maximum active range of motion, frequency and amplitude of tremor).	—

Secondary

Measure	Time frame
Clinical test scores (i.e., the TWSTRS, with subscales motor severity, disability and pain) for CD and ET patients. Other: age, sex, disease duration, current medication use (type, dose and frequency), outcome parameters related to usability of the technique to be developed (i.e., number of patients eligible for the study, number of patients invited, number of patients willing to participate, number of completed measurements, reasons for drop-out) and outcome parameters related to patient friendliness (i.e., duration of the experiment, participant experiences, numeric rating scale for pain and perceived strain).	—

Measure

Time frame

Clinical test scores (i.e., the TWSTRS, with subscales motor severity, disability and pain) for CD and ET patients. Other: age, sex, disease duration, current medication use (type, dose and frequency), outcome parameters related to usability of the technique to be developed (i.e., number of patients eligible for the study, number of patients invited, number of patients willing to participate, number of completed measurements, reasons for drop-out) and outcome parameters related to patient friendliness (i.e., duration of the experiment, participant experiences, numeric rating scale for pain and perceived strain).

—

Countries

Netherlands

Outcome results